Correlation Between Zoetis and Lumos Pharma
Can any of the company-specific risk be diversified away by investing in both Zoetis and Lumos Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zoetis and Lumos Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zoetis Inc and Lumos Pharma, you can compare the effects of market volatilities on Zoetis and Lumos Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zoetis with a short position of Lumos Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zoetis and Lumos Pharma.
Diversification Opportunities for Zoetis and Lumos Pharma
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Zoetis and Lumos is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Zoetis Inc and Lumos Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lumos Pharma and Zoetis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zoetis Inc are associated (or correlated) with Lumos Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lumos Pharma has no effect on the direction of Zoetis i.e., Zoetis and Lumos Pharma go up and down completely randomly.
Pair Corralation between Zoetis and Lumos Pharma
If you would invest 16,175 in Zoetis Inc on December 28, 2024 and sell it today you would earn a total of 327.00 from holding Zoetis Inc or generate 2.02% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Zoetis Inc vs. Lumos Pharma
Performance |
Timeline |
Zoetis Inc |
Lumos Pharma |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Zoetis and Lumos Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Zoetis and Lumos Pharma
The main advantage of trading using opposite Zoetis and Lumos Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zoetis position performs unexpectedly, Lumos Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lumos Pharma will offset losses from the drop in Lumos Pharma's long position.Zoetis vs. Emergent Biosolutions | Zoetis vs. Bausch Health Companies | Zoetis vs. Neurocrine Biosciences | Zoetis vs. Teva Pharma Industries |
Lumos Pharma vs. Shattuck Labs | Lumos Pharma vs. Champions Oncology | Lumos Pharma vs. Century Therapeutics | Lumos Pharma vs. Silo Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Complementary Tools
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |